"Consolidated list of products whose consumption and sale have been banned withdrawn, reverely restricted or not approved by governments."
Material type:
TextLanguage: English Series: ; Ed 4thPublication details: New Yrok United Nations U S A 1997Subject(s): DDC classification: - "X9(F56):1:(Z,95984).1.N9, UN"
| Item type | Current library | Home library | Call number | Vol info | Status | Barcode | |
|---|---|---|---|---|---|---|---|
Reference
|
Ratan Tata Library | Ratan Tata Library | "X9(F56):1:(Z,95984).1.N9 UN" (Browse shelf(Opens below)) | Ed 4th | Not for loan | RT1117960 |
Browsing Ratan Tata Library shelves Close shelf browser (Hides shelf browser)
| "X9(F56):1:(Z,95984).1.N9 UN" "Consolidated list of products whose consumption and sale have been banned withdrawn, reverely restricted or not approved by governments." | "X9(F56):1:(Z,95984).1.N9 UN" "Consolidated list of products whose consumption and sale have been banned withdrawn, reverely restricted or not approved by governments." | "X9(F56):1:(Z,95984).1.N9 UN" "Consolidated list of products whose consumption and sale have been banned withdrawn, reverely restricted or not approved by governments." | "X9(F56):1:(Z,95984).1.N9 UN" "Consolidated list of products whose consumption and sale have been banned withdrawn, reverely restricted or not approved by governments." | "X9(F56):545p2,N5 K5" Conclusions and recommendations | "X9(F56):76.2 P2/Th" Transfer pricing in conglomerates and multinationals a study of select pharma companies in India. | "X9(F56):77.1(X).N7 L8/UN" Growth of the pharmaceutical industry in developing countries Problems & prospects |
There are no comments on this title.
Log in to your account to post a comment.